Showing results (401-410 of 517) with videos related to

Sort By:
Pageof 52
Journal of General Internal Medicine|June 30, 2012
Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trialAsqual Getaneh, Laney S Light, David J Brillon, et al.
EMBO Molecular Medicine|June 10, 2018
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanismsHélène Fe Gleitz, Ai Yin Liao, James R Cook, et al.
Circulation|March 15, 1996
Patency of infarct-related artery. Effect of restoration of anterograde flow on vagal reflexes. ATRAMI (Automatic Tone and Reflexes After Myocardial Infarction) InvestigatorsA Mortara, G Specchia, M T La Rovere, et al.
Journal of Psychiatric Practice|June 30, 2005
Cardiovascular health and depressionAlexander Glassman, Peter A Shapiro, Daniel E Ford, et al.
The American Journal of Cardiology|August 28, 2014
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Omid Fatemi, Eugene Yuriditsky, Costas Tsioufis, et al.
Circulation|April 25, 2001
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trialsM T La Rovere, G D Pinna, S H Hohnloser, et al.
Gastroenterology|May 16, 2006
The bone marrow functionally contributes to liver fibrosisFrancesco P Russo, Malcolm R Alison, Brian W Bigger, et al.
Mutation Research|December 5, 2006
Strategy for genotoxicity testing--metabolic considerationsWarren W Ku, Anita Bigger, Giovanni Brambilla, et al.
Scientific Reports|October 3, 2019
Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomesTroy C Lund, Weston P Miller, Ai Yin Liao, et al.
Journal of Inherited Metabolic Disease|December 21, 2010
Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseasesKia Jane Langford-Smith, Jean Mercer, June Petty, et al.
Pageof 52